Frédéric Lacombe

Title: Frédéric Lacombe: Innovator in Pharmaceutical Formulations

Introduction

Frédéric Lacombe is a notable inventor based in Sant Cugat de Valles, Spain. He has made significant contributions to the field of pharmaceutical formulations, holding two patents that showcase his innovative approach to drug delivery systems.

Latest Patents

Lacombe's latest patents include "Sustained release formulations comprising very low molecular weight polymers." This invention relates to a parenteral, sustained and controlled release, semisolid formulation that comprises an end-capped oligomer and at least one active substance without any supplementary viscosity reducing agent or excipient. Another significant patent is the "Catalytic lactide and glycolide (co)polymerization system," which involves a catalytic lactide and glycolide copolymerization system that utilizes a trifluoromethane sulfonate as a catalyst and copolymerization additive, along with a copolymerization process.

Career Highlights

Frédéric Lacombe is currently associated with Ipsen Pharma S.a.s., where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that enhance the efficacy and safety of therapeutic agents.

Collaborations

Lacombe has collaborated with notable colleagues, including Roland Cherif-Cheikh and Didier Bourissou, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Frédéric Lacombe's contributions to the field of pharmaceutical formulations highlight his role as an innovator dedicated to improving drug delivery systems. His patents reflect a commitment to advancing medical science and enhancing patient care.